NREMT PARAMEDIC LEVEL • MEDICAL/OBSTETRICS/GYNECOLOGY

Toxicology and Overdose Management

Master the systematic assessment and treatment of poisoned patients in the prehospital setting.

Historical Context & Motivation

The discipline of toxicology — the science of poisons — stretches back thousands of years, but its systematic integration into emergency medical services is a distinctly modern development. Ancient Egyptian papyri catalogued plant poisons as early as 1500 BCE, and the Roman physician Galen recognized dose-dependent toxicity in the second century CE. However, the formalization of toxicology as a rigorous discipline did not occur until the work of Mathieu Orfila in the early nineteenth century, who is widely regarded as the father of modern toxicology. Orfila's emphasis on correlating chemical analysis with clinical findings laid the foundation for the evidence-based approach that paramedics use today when managing poisoned patients in the field.

The evolution of prehospital toxicology management has been shaped by public health crises, pharmaceutical innovation, and a growing understanding of toxidromes — recognizable constellations of signs and symptoms caused by specific classes of toxins. The twentieth and twenty-first centuries brought a dramatic expansion in the number and variety of substances to which people are exposed, from industrial chemicals and prescription medications to synthetic opioids and novel psychoactive substances. This expanding threat landscape has necessitated continuous updates to prehospital protocols and has elevated toxicology to a core competency for paramedic practice.

1814
Orfila Publishes Traité des Poisons
Mathieu Orfila publishes the first systematic treatise on toxicology, establishing the correlation between chemical agents and their physiological effects — a framework still central to clinical toxicology.
1958
First Poison Control Center Network
The American Association of Poison Control Centers (AAPCC) is formed, creating a national system for tracking and advising on poisoning exposures, directly informing prehospital treatment guidelines.
1971
Naloxone Approved by the FDA
Naloxone (Narcan) receives FDA approval as a specific opioid antagonist, transforming the prehospital management of opioid overdose and establishing the principle of targeted antidote therapy in EMS.
1997
Position Statement on Gastric Decontamination
The American Academy of Clinical Toxicology and the European Association of Poisons Centres publish landmark position statements limiting routine use of syrup of ipecac and gastric lavage, shifting prehospital focus toward activated charcoal and supportive care.
2010s–Present
Synthetic Opioid and NPS Epidemic
The emergence of fentanyl analogs and novel psychoactive substances (NPS) drives a dramatic increase in overdose fatalities and demands updated paramedic training in high-dose naloxone protocols and novel toxidrome recognition.

The central question that drives prehospital toxicology is this: when confronted with a patient whose clinical presentation may be caused by one of tens of thousands of possible toxic agents, how does the paramedic rapidly identify the offending substance class, anticipate clinical deterioration, and initiate life-saving interventions — often with limited history and no laboratory data? The answer lies in a systematic approach built on toxidrome recognition, aggressive airway management, targeted antidote administration, and supportive care.

Core Principles of Toxicology Management

Effective prehospital toxicology management rests on several foundational principles that guide the paramedic from scene assessment through transport. The sixteenth-century physician Paracelsus famously declared that "the dose makes the poison," and this axiom remains the cornerstone of toxicological thinking. Every substance — from water to arsenic — has a threshold above which it becomes harmful, and the paramedic's task is to understand the dose-response relationship well enough to anticipate the severity and trajectory of a toxic exposure. Beyond dose, the route of exposure (ingestion, inhalation, injection, absorption) profoundly influences onset time, peak effect, and duration of toxicity.

1

Scene Safety & Exposure Control

The poisoned patient scene may itself be hazardous. Before patient contact, assess for ongoing toxic exposures — gas leaks, clandestine drug labs, or chemical spills — and ensure appropriate PPE. Scene safety is the first priority in every toxicological emergency.
2

Toxidrome Recognition

A toxidrome is a syndrome produced by a class of toxic agents, characterized by a predictable cluster of vital sign abnormalities, pupil changes, skin findings, and mental status alterations. Recognizing the toxidrome directs empiric treatment even before the exact agent is identified.
3

Supportive Care First

The majority of poisoned patients are managed with aggressive supportive care — airway protection, oxygenation, ventilation, IV access, and hemodynamic support. Specific antidotes exist for only a limited subset of toxins; supportive care saves more lives than any single antidote.
4

Targeted Antidote Therapy

When a specific antidote is available and indicated — naloxone for opioids, atropine and pralidoxime for organophosphates, flumazenil for benzodiazepines (with caution) — prompt administration can be life-saving. Knowledge of indications, contraindications, and dosing is essential.
5

Decontamination & Elimination Enhancement

Reducing ongoing absorption (activated charcoal, skin decontamination) and enhancing elimination (sodium bicarbonate for urinary alkalinization, whole bowel irrigation) are secondary strategies that may reduce total toxic burden when applied within appropriate time windows.
KEY TAKEAWAY
Think of prehospital toxicology management like an emergency room triage system: you do not need to identify the exact brand of poison to begin life-saving treatment. Just as an ER nurse triages by acuity rather than diagnosis, a paramedic triages by toxidrome pattern rather than specific agent. Recognizing whether the patient fits a sympathomimetic, cholinergic, opioid, or sedative-hypnotic pattern allows you to initiate the correct empiric interventions immediately — much like sorting patients into treatment streams before all lab results return.

Visual Explanation — The Major Toxidromes

The following diagram presents the five major toxidromes that a paramedic must be able to identify rapidly in the field. Each toxidrome is characterized by a distinct constellation of findings across four assessment domains: vital signs, pupil response, skin findings, and mental status. By systematically evaluating these four domains, the paramedic can rapidly categorize the patient's presentation and guide initial management even before a specific toxicant is identified.

The five major toxidromes are arranged as diagnostic cards showing vital sign patterns, pupil findings, skin characteristics, and mental status changes. The key differentiators section at the bottom highlights the critical distinctions between toxidromes that can appear clinically similar — for example, both sympathomimetic and anticholinergic toxidromes produce mydriasis and tachycardia, but the presence or absence of diaphoresis separates them.

When assessing a potentially poisoned patient, begin with the standard primary survey (airway, breathing, circulation) and integrate toxidrome assessment into the secondary survey. Note the vital sign trends (not single values) — a patient whose heart rate is rising at 10 beats per minute on serial assessments tells a different story than one with a stable tachycardia. Pupil size should be assessed early and documented because pharmacological changes can occur rapidly. Skin assessment — particularly moisture, temperature, and color — is often the single most discriminating feature between otherwise similar toxidromes. A patient who is tachycardic with dilated pupils and drenched in sweat (sympathomimetic) requires fundamentally different management than one who is tachycardic with dilated pupils and bone-dry skin (anticholinergic).

Mechanism of Action — How Toxins Cause Harm

Understanding why toxic substances produce their characteristic effects requires a working knowledge of receptor pharmacology and cellular physiology. Most toxins of clinical significance produce their effects through one of several mechanisms: direct receptor agonism or antagonism, enzyme inhibition, ion channel disruption, metabolic poisoning, or direct tissue destruction. The paramedic does not need to recite the molecular pharmacology of each agent, but understanding the broad category of mechanism allows prediction of the clinical course and guides interventions.

Routes of Exposure and Onset Considerations

The route by which a toxin enters the body determines the speed of onset and the duration of effect. Intravenous injection provides essentially instantaneous delivery to the central circulation, with peak effects within seconds to minutes. Inhalation exposure is nearly as rapid due to the vast surface area of the pulmonary capillary bed. Oral ingestion is the most common route in intentional overdose; onset depends on gastric contents, formulation (immediate-release vs. extended-release), and first-pass hepatic metabolism, typically ranging from 30 minutes to several hours. Dermal absorption is generally the slowest route, though certain agents — organophosphate pesticides, hydrofluoric acid — can achieve toxic systemic concentrations through skin contact alone.

Pharmacokinetic Considerations in Overdose

DRUG HALF-LIFE RELATIONSHIP
C(t) = C₀ × (½)^(t / t½)
Where C(t) = plasma concentration at time t, C₀ = initial plasma concentration, and = elimination half-life. In overdose, metabolic pathways may become saturated (zero-order kinetics), dramatically prolonging effective half-life.

In therapeutic dosing, most drugs follow first-order elimination kinetics — a constant fraction of the drug is eliminated per unit time, and the half-life remains stable regardless of dose. However, in massive overdose, hepatic enzyme systems and renal excretion mechanisms can become saturated, causing a shift to zero-order kinetics where a fixed amount (not fraction) is eliminated per unit time. This is why acetaminophen overdose, for example, can overwhelm the conjugation pathways of the liver and lead to accumulation of the toxic metabolite NAPQI, resulting in fulminant hepatic failure. The clinical implication for the paramedic is that patients who appear stable after a massive ingestion may deteriorate dramatically hours later as the drug continues to be absorbed from the GI tract.

⚕️ Clinical Pearl
Extended-release and enteric-coated formulations present a unique danger: the patient may present with minimal symptoms initially, but clinical deterioration can be sudden and severe as the drug matrix releases its full payload. Always ask about the specific formulation ingested and contact Poison Control (1-800-222-1222) for guidance on anticipated delayed toxicity.

Detailed Breakdown — Common Agents and Their Antidotes

While the toxidrome-based approach provides the initial framework for management, paramedics must also have detailed knowledge of the most commonly encountered toxic agents and their specific antidotes. The following classification organizes these agents by clinical category, lists the hallmark findings that distinguish them, and identifies the antidotes that should be considered in the prehospital setting. Understanding which antidotes are carried on a paramedic unit versus those available only at the receiving facility is essential for effective triage and transport decisions.

This prehospital overdose management algorithm illustrates the systematic approach from scene arrival through transport. The decision tree emphasizes airway management as the first critical branch point, followed by toxidrome identification and agent-specific antidote selection. Note that for unknown ingestions, empiric treatment and rapid transport with Poison Control consultation are prioritized.
Common Toxic Agents, Hallmark Findings, and Antidotes
Agent ClassHallmark FindingsPrehospital AntidoteKey Dosing Notes
OpioidsPinpoint pupils, respiratory depression, CNS depression; classic triadNaloxone (Narcan)0.4−2 mg IV/IM/IN; titrate to respiratory effort, not consciousness; may need repeat doses for fentanyl
OrganophosphatesSLUDGE/DUMBELS: salivation, lacrimation, urination, defecation, emesis, miosis, bradycardiaAtropine + Pralidoxime (2-PAM)Atropine 2−4 mg IV q5min until secretions dry; 2-PAM 1−2 g IV over 15−30 min
Tricyclic Antidepressants (TCAs)Wide QRS > 100 ms, anticholinergic toxidrome, seizures, hypotensionSodium Bicarbonate1−2 mEq/kg IV bolus; target QRS narrowing; repeat PRN to maintain serum pH 7.45−7.55
Beta-BlockersProfound bradycardia, hypotension, hypoglycemia, bronchospasm (non-selective)Glucagon3−5 mg IV bolus; bypasses beta receptor blockade via cAMP stimulation; may cause vomiting
Calcium Channel BlockersBradycardia, hypotension, hyperglycemia (distinguishes from beta-blocker OD)Calcium Chloride or GluconateCaCl₂ 1 g IV slowly; glucagon as adjunct; high-dose insulin therapy at hospital
BenzodiazepinesCNS depression, respiratory depression, normal pupils, hypotoniaFlumazenil (use with caution)0.2 mg IV over 30s; can precipitate seizures in chronic benzo users or mixed ingestions — use is controversial
AcetaminophenOften asymptomatic early; RUQ pain and hepatic failure delayed 24−72 hoursN-Acetylcysteine (hospital)Not typically prehospital; ensure rapid transport; most effective within 8 hours of ingestion

Worked Example — Opioid Overdose Management

The following scenario demonstrates the systematic approach to managing a suspected opioid overdose in the prehospital setting, integrating toxidrome recognition, primary survey interventions, and targeted antidote therapy.

Scenario: Suspected Fentanyl Overdose
1
Step 1 — Scene Size-Up and SafetyEMS is dispatched to a residence for an unresponsive male. On arrival, bystanders state they found the patient in the bathroom with drug paraphernalia nearby. The scene is assessed for hazards — no volatile chemicals or weapons are noted. The paramedic dons gloves and ensures no powder residue is aerosolized. Appropriate BSI/PPE precautions are taken. The number of patients is confirmed as one.
Scene safe; single patient; drug paraphernalia on scene suggests substance use
2
Step 2 — Primary Survey (ABCs)The patient is a 28-year-old male, supine on the bathroom floor. He is unresponsive to verbal and painful stimuli (GCS 3). Airway: patent but with sonorous respirations suggesting posterior pharyngeal obstruction. Breathing: respiratory rate is 4 breaths per minute with shallow tidal volume; SpO₂ is 72% on room air. Circulation: radial pulse is weak and bradycardic at approximately 52 bpm; skin is cool, cyanotic, and diaphoretic. The paramedic immediately repositions the airway with a jaw-thrust maneuver and begins BVM ventilation with high-flow oxygen.
Life-threatening respiratory depression identified; BVM ventilation initiated
3
Step 3 — Toxidrome IdentificationDuring BVM ventilation, the paramedic performs a rapid toxidrome assessment. Pupils are examined with a penlight and found to be pinpoint (miotic) bilaterally. Skin is cool and cyanotic. The clinical triad of CNS depression + respiratory depression + miosis is consistent with the opioid toxidrome. Drug paraphernalia on scene further supports this assessment. Given the prevalence of illicit fentanyl, the paramedic anticipates the potential need for higher-than-standard naloxone dosing.
Opioid toxidrome confirmed: CNS depression + respiratory depression + pinpoint pupils
4
Step 4 — Antidote AdministrationWhile the partner continues BVM ventilation, the paramedic establishes IV access in the right antecubital fossa and administers naloxone 2 mg IV. The goal is to restore adequate spontaneous respirations (RR ≥ 12), not full consciousness — over-reversal may precipitate acute withdrawal with agitation, vomiting, and aspiration risk. After 2 minutes, the patient's respiratory rate increases to 8 bpm. A second dose of naloxone 2 mg IV is administered. Within 3 minutes of the second dose, respiratory rate improves to 14 bpm, SpO₂ rises to 94%, and the patient begins to respond to verbal stimuli (GCS improves to 10).
Total naloxone: 4 mg IV; respiratory rate improved from 4 → 14 bpm; SpO₂ 72% → 94%
5
Step 5 — Ongoing Assessment and TransportThe paramedic places the patient on continuous cardiac monitoring, capnography, and pulse oximetry. Because naloxone's duration of action (30−90 minutes) is typically shorter than that of most opioids — and significantly shorter than fentanyl's tissue redistribution time — the patient is at risk for renarcotization (recurrence of respiratory depression as naloxone wears off). Serial vital signs are assessed every 5 minutes during transport. The patient is transported to the nearest facility with toxicology capabilities. All drug paraphernalia and pill bottles from the scene are collected for hospital evaluation.
Continuous monitoring during transport; anticipate renarcotization; bring scene evidence to ED
💉 Naloxone Dosing Considerations for Fentanyl
Fentanyl analogs may require significantly higher cumulative doses of naloxone (up to 10−12 mg or more) due to their high receptor affinity and lipophilicity. If the patient does not respond to initial doses, continue BVM ventilation and escalate naloxone dosing per local protocol. Some systems have adopted naloxone infusions (two-thirds of the effective bolus dose per hour) for sustained reversal during transport.

Decontamination Strategies — Strengths and Limitations

Gastrointestinal decontamination has undergone a significant evolution in clinical thinking over the past three decades. Procedures that were once routine — ipecac-induced emesis, routine gastric lavage — have been largely abandoned in both the emergency department and prehospital settings based on evidence of limited efficacy and significant complication rates. The current approach is far more nuanced, emphasizing careful patient selection, time-to-ingestion considerations, and risk-benefit analysis for each decontamination modality.

Comparison of Gastrointestinal and Surface Decontamination Methods
Decontamination MethodStrengthsLimitations / Risks
Activated Charcoal (AC)Broad adsorptive capacity for most organic compounds; can be given prehospitally via oral route; relatively safe when patient has intact airway and gag reflex; most effective within 1 hour of ingestionDoes NOT adsorb metals (iron, lithium), alcohols, or corrosives; aspiration risk in altered patients; may cause vomiting; contraindicated if airway is not protected; limited evidence for benefit beyond 1−2 hours post-ingestion
Whole Bowel Irrigation (WBI)Effective for sustained-release formulations, body-packing, and substances not adsorbed by charcoal (iron, lithium); uses polyethylene glycol solution (GoLYTELY)Typically hospital-based procedure; requires large volumes (1−2 L/hr in adults); contraindicated in ileus, obstruction, or hemodynamic instability; logistically difficult prehospitally
Skin DecontaminationCritical for organophosphate, chemical, and hazmat exposures; reduces ongoing dermal absorption; copious water irrigation is the standard; removes contaminant before transportRequires adequate water supply; risk of secondary contamination to providers if not performed properly; must remove all clothing (cutting away, not pulling over head); cold stress risk in field setting
Gastric LavageMay be considered within 1 hour of life-threatening ingestion when other methods are not feasible; can recover pill fragments for identificationLargely abandoned; risk of aspiration, esophageal perforation, and vagal stimulation; limited evidence of benefit; generally NOT performed prehospitally; requires intubation for airway protection
Syrup of IpecacHistorically first-line for home poisoning; reliably induces emesisNo longer recommended by AAP, AACT, or EAPCCT; delays definitive care; risk of aspiration; incomplete gastric emptying; prolonged vomiting interferes with AC or antidote administration
KEY TAKEAWAY
Think of decontamination like containing a chemical spill in a factory. The most effective strategy depends on when you arrive relative to the spill. If you arrive in the first hour, activated charcoal is like deploying absorbent booms before the chemical spreads into the drainage system. If you arrive late, the chemical has already entered the waterways (the bloodstream), and your focus shifts entirely to downstream treatment — antidotes and supportive care. The critical lesson is that decontamination is time-sensitive and should never delay life-saving airway management or antidote administration.

Connection to Advanced Toxicology and Hospital-Based Care

Prehospital toxicology management represents the critical first link in a chain of care that extends through emergency department resuscitation, inpatient critical care, and sometimes specialized interventions such as hemodialysis or lipid emulsion therapy. Understanding how prehospital interventions connect to these advanced modalities helps the paramedic prioritize actions, select the appropriate receiving facility, and communicate effectively during patient handoff. The following table compares prehospital and hospital-based capabilities for several high-acuity toxicological emergencies.

Prehospital vs. Hospital-Based Toxicology Management
Clinical ScenarioPrehospital ManagementHospital-Based Advanced Therapy
Massive TCA overdose with wide QRS and seizuresNaHCO₃ bolus, benzodiazepines for seizures, aggressive airway management, avoid Class IA/IC antiarrhythmicsContinuous NaHCO₃ infusion, intralipid emulsion therapy (ILE) for refractory cardiovascular collapse, mechanical ventilation, vasopressor support
Methanol or ethylene glycol ingestionSupportive care, IV access, treat metabolic acidosis with NaHCO₃ if available; rapid transportFomepizole (4-MP) or ethanol infusion to inhibit alcohol dehydrogenase; hemodialysis for severe cases; serial metabolic panels
Acetaminophen massive ingestionActivated charcoal if within 1 hour and airway intact; rapid transport; document time and amount of ingestionN-Acetylcysteine (NAC) IV protocol (most effective <8 hrs); Rumack-Matthew nomogram for risk stratification; hepatology consult; liver transplant evaluation if indicated
Cyanide exposure (fire, industrial)Hydroxocobalamin (Cyanokit) 5 g IV if available; high-flow O₂; avoid mouth-to-mouth; decontaminateContinued hydroxocobalamin; sodium thiosulfate; supportive ICU care; hyperbaric oxygen if concurrent CO poisoning
Local anesthetic systemic toxicity (LAST)ACLS-compliant resuscitation; avoid vasopressin and calcium channel blockers; small-dose epinephrine only20% intralipid emulsion bolus + infusion (lipid rescue); cardiopulmonary bypass if refractory cardiac arrest

The emerging role of intralipid emulsion therapy (ILE) represents one of the most significant advances in toxicology resuscitation in the past two decades. Originally developed for local anesthetic systemic toxicity, ILE has shown promise in managing overdoses of lipophilic drugs including calcium channel blockers, beta-blockers, and tricyclic antidepressants. Some EMS systems have begun carrying 20% lipid emulsion for use in cardiac arrest secondary to suspected lipophilic drug overdose, bridging what was previously an exclusively hospital-based intervention into the prehospital arena.

Looking forward, advances in point-of-care testing — including handheld immunoassay devices and novel biosensors — may eventually allow prehospital providers to identify specific toxins at the bedside, further personalizing treatment. For now, the paramedic's most powerful tools remain a systematic assessment framework, mastery of the major toxidromes, and fluency with the handful of critical antidotes that are available in the field.

Practice Problems

PROBLEM 1CONCEPTUAL
A patient presents with tachycardia, mydriasis, hypertension, and profuse diaphoresis after suspected cocaine use. Another patient has tachycardia, mydriasis, hypertension, and dry, flushed skin after ingesting an unknown pill. Both patients share several overlapping findings. What is the single most important clinical finding that distinguishes the sympathomimetic toxidrome from the anticholinergic toxidrome, and why does this distinction matter for management?
PROBLEM 2BASIC CALCULATION
A 70 kg patient with suspected organophosphate poisoning is displaying the SLUDGE symptoms with copious oral secretions and a heart rate of 42 bpm. Your protocol calls for atropine 0.05 mg/kg IV as the initial dose for organophosphate poisoning. Calculate the initial dose in milligrams. Your atropine comes in 1 mg/10 mL prefilled syringes. How many milligrams and milliliters will you administer for the first dose?
PROBLEM 3INTERMEDIATE
You are called to a residence where a 45-year-old female was found unresponsive by her husband. On the nightstand, you find an empty bottle of amitriptyline (a tricyclic antidepressant) and a half-empty bottle of wine. The patient is unresponsive (GCS 6), has a heart rate of 128 bpm, BP 82/48, and a 12-lead ECG shows a QRS duration of 160 ms with a rightward axis. Describe your management priorities in order, and explain why the QRS width is clinically significant in this presentation.
PROBLEM 4APPLIED
You respond to a call where a 3-year-old child was found by his mother playing with an open bottle of her metoprolol (a beta-blocker) tablets. The mother estimates that approximately 10 tablets of metoprolol succinate 100 mg ER may be missing, though she is unsure of the exact number. The child is currently alert, with a heart rate of 95 bpm, BP 88/60 (age-appropriate low-normal), and appears well. Discuss your assessment, management, and transport considerations. Why is the extended-release formulation of particular concern in this scenario?
PROBLEM 5CRITICAL THINKING
A 32-year-old female with a known history of epilepsy managed with phenobarbital presents after an intentional overdose of an unknown quantity of her phenobarbital tablets. She is somnolent but rousable (GCS 11), with respiratory rate of 10, SpO₂ 91%, and bilateral miotic pupils. A bystander urges you to administer flumazenil because 'it reverses sedative overdoses.' Critically evaluate this suggestion. Under what circumstances might flumazenil be indicated in sedative-hypnotic overdose, and why is it contraindicated in this specific patient? Discuss the broader pharmacological principle that informs this decision.

Summary — Toxicology and Overdose Management

Prehospital toxicology management is built on a systematic approach that begins with scene safety and exposure control and progresses through primary survey with aggressive airway management to toxidrome recognition. The five major toxidromes — sympathomimetic, cholinergic, anticholinergic, opioid, and sedative-hypnotic — provide a pattern-recognition framework that guides empiric treatment even before the specific agent is identified. Key differentiating features include skin moisture (sympathomimetic vs. anticholinergic), pupil size (opioid vs. sedative-hypnotic), and secretion patterns (cholinergic vs. opioid).

The cornerstone of management is supportive care, with specific antidotes reserved for identified toxidromes: naloxone for opioids, atropine and pralidoxime for organophosphates, sodium bicarbonate for TCA-induced wide QRS, and glucagon for beta-blocker toxicity. Decontamination — primarily activated charcoal within 1 hour of ingestion — is a secondary measure that should never delay airway management or antidote therapy. Extended-release formulations demand heightened vigilance due to delayed peak effects, and renarcotization risk requires continuous monitoring after naloxone administration. Always bring scene evidence to the receiving facility and consult Poison Control (1-800-222-1222) for guidance on unfamiliar agents.

Varsity Tutors • NREMT Paramedic Level • Toxicology and Overdose Management